Clorox will report its fiscal Q1 2027 earnings on November 2, with investors watching closely to see if cash flow can sustain its $5 annual dividend, yielding about 5.7%. The company faces heavy cost inflation, with gross margins already down 520 basis points last quarter due to higher commodity and logistics costs. While the Health and Wellness segment grew, Household and Lifestyle segments declined, and analysts have lowered earnings estimates recently. The dividend's safety hinges on whether margins hold near the 42% target and if free cash flow supports the payout, especially as the payout ratio is currently high at about 88% of expected earnings. The upcoming report will be critical for confirming if Clorox can maintain its decade-long streak of dividend increases amid these challenges.
Clorox trades at USD 86.01 on Pluang as of Oct 27, 2026 20:31 WIB, down 0.86% for the day. The stock shows a dividend yield of 5.76% with a market cap of $10.49 billion. All Pluang orders are currently buys, reflecting investor interest ahead of the November 2 earnings report.
